Newswise — PHILADELPHIA—While initial reports suggested a significant risk of stroke in patients hospitalized with COVID-19, a new paper published in Stroke from Penn Medicine shows a low risk of stroke in patients hospitalized for COVID-19. Notably, the majority of afflicted patients had existing risk factors, such as high blood pressure and diabetes. These findings provide more clarity about the role COVID-19 plays in causing stroke in a diverse population of the United States.
“While there was initial concern for a high number of strokes related to COVID-19, that has not been born out. Importantly, while the risk for stroke in COVID-19 patients is low, it’s mostly tied to pre-existing conditions—so physicians who do see stroke in hospitalized COVID-19 patients must understand the virus is not the only factor, and it’s necessary to follow through with normal diagnostic testing,” said Brett Cucchiara, MD, an associate professor of Neurology in the Perelman School of Medicine at the University of Pennsylvania, and senior author of the paper. “However, there are still many unknowns and we need to continue investigating the linkage between stroke and COVID-19, particularly considering the racial disparities surrounding the disease.”
To evaluate the risk and incidence of stroke in COVID-19 hospitalized patients, researchers analyzed data from 844 COVID-19 patients admitted to the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, and Pennsylvania Hospital between March and May. The team also analyzed the data for cases of intracranial hemorrhage (bleeding in the brain).
Researchers found that 2.4 percent of patients hospitalized for COVID-19 had an ischemic stroke—the most common type of stroke, typically caused by a blood clot in the brain. Importantly, the majority of these stroke patients had existing risk factors, such as high blood pressure (95 percent) and a history of diabetes (60 percent), and traditional stroke mechanisms, such as heart failure. Additionally, over one-third had a history of a previous stroke.
Researchers say the results suggest that these cerebrovascular events in hospitalized COVID-19 patients are likely tied to existing conditions, and not the sole consequence of the virus. However, other factors could be at play and require continued research. While the precise mechanisms linking cerebrovascular events to COVID-19 remain uncertain at this time, it has recently been reported that the viral infection, SARS-CoV-2, causes inflammation and a hypercoagulable state (excessive blood clotting)—both could be potential mechanisms leading to stroke.
The population of patients for the study was unique as well, with a more diverse cohort compared to previous reported studies. Black patients accounted for 68 percent of the study population and of the hospitalized patients who had a stroke, 80 percent were Black.
“This aligns with the data we’re seeing on the racial disparities of the virus across our country,” said Cucchiara. “We worry that this could further indicate the higher risks associated with COVID-19 in Black populations, much more so than white. So far, we don’t understand the disproportionate effect we’re seeing, but the disparities in infection rates and outcomes is incredibly important to figure out and address.”
In addition to the incidents of stroke, the research team found that 0.9 percent of hospitalized COVID-19 patients had intracranial hemorrhage. While the rate of stroke in hospitalized COVID-19 patients is comparable to studies in Wuhan, China and Italy, the rate of intracranial hemorrhage, which has not previously been reported, is higher than investigators expected. The authors note this could be tied to the increasing use of anticoagulant therapy (blood thinners) in COVID-19 patients, and requires additional exploration.
Notably, there was a relatively long duration of time from initial COVID-19 symptoms to diagnosis of ischemic stroke, at an average of 21 days. This finding is consistent with increasing evidence of a hypercoagulable state which evolves over the initial weeks of the disease in many patients, and requires further study, the authors note.
The cohort of patients had an average age of 59 years, and the mean age of the ischemic stroke patients was 64 years, with only one patient under age 50. This finding differs significantly from early reports that raised concern there might be a high rate of stroke among younger patients.
Additional Penn authors include Aaron Rothstein, Olivia Oldridge, Hannah Schwennesen, and David Do.
###
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.
RSS